CaixaBank, S.A. (CAIXY)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49,190	3,849	4,157	4,138	4,642	3,076
Investment Securities	177,517	174,428	170,049	166,809	87,313	47,654
Trading Asset Securities	14,687	6,140	7,963	8,091	12,914	8,158
Total Investments	192,204	180,568	178,012	174,900	100,227	55,812
Gross Loans	385,786	372,264	362,569	372,360	360,681	248,426
Allowance for Loan Losses	-	-6,686	-7,330	-7,401	-8,260	-5,609
Other Adjustments to Gross Loans	-	-401	-428	-427	-436	-357
Net Loans	385,786	365,177	354,811	364,532	351,985	242,460
Property, Plant & Equipment	6,807	5,712	5,877	5,919	6,398	4,950
Goodwill	-	3,094	3,094	3,167	3,455	3,051
Other Intangible Assets	5,097	1,979	1,893	1,857	1,478	898
Investments in Real Estate	-	1,263	1,423	1,597	1,865	2,007
Accrued Interest Receivable	-	1,572	1,454	786	475	464
Other Receivables	-	2,917	1,974	2,741	2,229	835
Restricted Cash	-	45,955	33,704	16,384	99,574	48,535
Other Current Assets	302	1,554	1,633	1,813	2,107	282
Long-Term Deferred Tax Assets	-	15,224	16,954	18,304	19,493	9,794
Other Real Estate Owned & Foreclosed	1,273	566	635	777	1,027	991
Other Long-Term Assets	19,163	1,573	1,546	1,935	85,081	78,365
Total Assets	659,822	631,003	607,167	598,850	680,036	451,520
Accrued Expenses	-	-	-	-	-	1,219
Interest Bearing Deposits	465,183	423,993	399,682	416,952	476,025	300,523
Total Deposits	465,183	423,993	399,682	416,952	476,025	300,523
Short-Term Borrowings	4,052	21,836	27,468	14,905	16,972	2,002
Current Income Taxes Payable	-	1,458	748	452	189	222
Other Current Liabilities	-	4,381	4,783	4,057	3,550	3,429
Long-Term Debt	51,174	56,563	56,755	52,608	53,684	35,813
Long-Term Leases	-	1,573	1,660	1,608	1,864	1,468
Long-Term Unearned Revenue	-	-	-	-	-	2
Pension & Post-Retirement Benefits	-	581	632	698	1,038	879
Long-Term Deferred Tax Liabilities	-	1,066	1,346	1,480	2,148	1,009
Other Long-Term Liabilities	101,978	82,686	77,754	72,383	89,141	79,676
Total Liabilities	622,387	594,137	570,828	565,143	644,611	426,242
Common Stock	7,086	7,175	7,502	7,502	8,061	5,981
Additional Paid-In Capital	-	12,309	13,470	13,470	15,268	12,033
Retained Earnings	2,951	20,505	19,741	16,781	15,007	10,100
Treasury Stock	-	-299	-519	-25	-19	-12
Comprehensive Income & Other	27,387	-2,858	-3,887	-4,053	-2,923	-2,849
Total Common Equity	37,424	36,832	36,307	33,675	35,394	25,253
Minority Interest	11	34	32	32	31	25
Shareholders' Equity	37,435	36,866	36,339	33,707	35,425	25,278
Total Liabilities & Equity	659,822	631,003	607,167	598,850	680,036	451,520
Total Debt	55,226	79,972	85,883	69,121	72,520	39,283
Net Cash (Debt)	8,651	-69,983	-73,763	-56,892	-54,964	-28,049
Net Cash Per Share	1.22	-9.64	-9.87	-7.28	-7.26	-4.69
Filing Date Shares Outstanding	7,069	7,118	7,367	7,494	8,053	5,977
Total Common Shares Outstanding	7,069	7,118	7,367	7,494	8,053	5,977
Book Value Per Share	5.29	5.17	4.93	4.49	4.39	4.22
Tangible Book Value	32,327	31,759	31,320	28,651	30,461	21,304
Tangible Book Value Per Share	4.57	4.46	4.25	3.82	3.78	3.56

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.